Gene · 10332
Papers1,514
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,514
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rare loss-of-function variants in matrisome genes are enriched in Ebstein's anomaly. | HGG Adv | 2024 | 38006208 | PubTator, text mining | PubMed |
| Coculture model of a liver sinusoidal endothelial cell barrier and HepG2/C3a spheroids-on-chip in an advanced fluidic platform. | J Biosci Bioeng | 2024 | 37973520 | PubTator, text mining | PubMed |
| Non-glycosylated G protein with CpG ODN provides robust protection against respiratory syncytial virus without inducing eosinophilia. | Front Immunol | 2023 | 38169867 | PubTator, text mining | PubMed |
| The Antiviral Activity of the Lectin Griffithsin against SARS-CoV-2 Is Enhanced by the Presence of Structural Proteins. | Viruses | 2023 | 38140693 | PubTator, text mining | PubMed |
| Interaction between Gut Microbiota and Dendritic Cells in Colorectal Cancer. | Biomedicines | 2023 | 38137417 | PubTator, text mining | PubMed |
| Lipid compartments and lipid metabolism as therapeutic targets against coronavirus. | Front Immunol | 2023 | 38106410 | PubTator, text mining | PubMed |
| The multiple roles of C-type lectin receptors in cancer. | Front Oncol | 2023 | 38090489 | PubTator, text mining | PubMed |
| Flying under the radar - impact and factors influencing asymptomatic DENV infections. | Front Cell Infect Microbiol | 2023 | 38076464 | PubTator, text mining | PubMed |
| Comprehensive Profiling and Therapeutic Insights into Differentially Expressed Genes in Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 38067357 | PubTator, text mining | PubMed |
| Calreticulin Regulates SARS-CoV-2 Spike Protein Turnover and Modulates SARS-CoV-2 Infectivity. | Cells | 2023 | 38067122 | PubTator, text mining | PubMed |
| Engineering irradiated tumor-derived microparticles as personalized vaccines to enhance anti-tumor immunity. | Cell Rep Med | 2023 | 38029750 | PubTator, text mining | PubMed |
| Levels of APE1 Repair Gene and CLEC4M in Lung Cancer Patients Receiving Cisplatin Chemotherapy. | Arch Razi Inst | 2023 | 38028841 | PubTator, text mining | PubMed |
| The matrix metalloproteinase ADAM10 supports hepatitis C virus entry and cell-to-cell spread via its sheddase activity. | PLoS Pathog | 2023 | 37967063 | PubTator, text mining | PubMed |
| Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors. | Int J Mol Sci | 2023 | 37958503 | PubTator, text mining | PubMed |
| The effect of single mutations in Zika virus envelope on escape from broadly neutralizing antibodies. | J Virol | 2023 | 37943046 | PubTator, text mining | PubMed |
| Unraveling DPP4 Receptor Interactions with SARS-CoV-2 Variants and MERS-CoV: Insights into Pulmonary Disorders via Immunoinformatics and Molecular Dynamics. | Viruses | 2023 | 37896834 | PubTator, text mining | PubMed |
| Avian influenza A viruses exhibit plasticity in sialylglycoconjugate receptor usage in human lung cells. | J Virol | 2023 | 37843369 | PubTator, text mining | PubMed |
| Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis. | Front Immunol | 2023 | 37841282 | PubTator, text mining | PubMed |
| Transcriptomics of mussel transmissible cancer MtrBTN2 suggests accumulation of multiple cancer traits and oncogenic pathways shared among bilaterians. | Open Biol | 2023 | 37816387 | PubTator, text mining | PubMed |
| Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses. | PLoS Pathog | 2023 | 37812640 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10332/papers?page=4